Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Cornerstone Genomics Launches CodeXome: A Revolutionary Tool for Genetic Research & Rare Disease Cures


News provided by

Cornerstone Genomics

Sep 10, 2024, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Cornerstone Genomics
Cornerstone Genomics

Cloud-based CodeXome offers a unique opportunity to study gene function and evolution across species

FREDERICK, Md., Sept. 10, 2024 /PRNewswire-PRWeb/ -- Cornerstone Genomics, a pioneer in advanced genomic research software, proudly announces the launch of CodeXome, a groundbreaking all-in-one platform designed to accelerate the discovery of genetic targets by providing researchers with extensive cross-species data. Tailored for genome scientists in academia, government, and private enterprise, the cloud-based CodeXome offers a unique opportunity to study gene function and evolution across species. Users can explore genes, test hypotheses, and even upload their own data for cross-referencing against Cornerstone Genomics' proprietary database.

Founder Jill Pecon-Slattery, who initiated the project in 2019, has overseen significant company growth leading up to CodeXome's 2024 release. She says, "I'm excited because it integrates multiple disciplines. Our platform uses genetic data that no one else has. Drawing insight from non-human primates - our extended family of monkeys, lemurs, marmosets, and others - allows scientists to reference individual genes and observe how they can evolve."

Founder Jill Pecon-Slattery, says, "I'm excited because it integrates multiple disciplines. Our platform uses genetic data that no one else has...(it) allows scientists to reference individual genes and observe how they can evolve."

Post this

"Most of these species are endangered," continues Pecon-Slattery, noting a growing global interest in conservation. "CodeXome not only aids researchers in drug development and disease diagnosis, but it also raises awareness about the conservation of endangered species, linking wildlife biodiversity with human biomedicine."

Cornerstone Genomics is a member of the Frederick Innovative Technology Center's (FITCI) new Maryland's EDGE at 321 in Frederick, Maryland. FITCI CEO Kathie Callahan Brady, a mentor and ardent supporter of the Cornerstone team, emphasizes CodeXome's importance. "Typically, there is less attention for understanding the genetics of these species," she explains. "That's what makes CodeXome so crucial. Scientists looking for cures to rare diseases or physicians working with individual subjects can unlock a wealth of comparative information that can help them advance their vital work right now."

Pecon-Slattery is passionate about Cornerstone Genomic's mission because, "I want to bring attention to larger societal issues, like preservation of species around the world." Importantly, CodeXome relies upon lab-grown cell lines, using very small initial samples, like commercial DNA tests, thereby safeguarding the lives of animals.

Early reviews praise CodeXome's blazing speed, intuitive interface, and access to a broad primate genome spectrum. "We are honored by the support of the National Science Foundation for our transformative approach," says Pecon-Slattery. The company received both Phase 1 and Phase 2 SBIR awards. "The NSF awards are significant milestones for us, reinforcing the value of CodeXome within the scientific community."

Pecon-Slattery concludes, "The bottom line is, if you know what's normal, you can better identify what's not. CodeXome cuts through the noise to provide clear, actionable insights for researchers tackling some of the most challenging genetic diseases."

About Cornerstone Genomics
Cornerstone Genomics is a pioneering company dedicated to advancing genomic research for the betterment of human health. By leveraging cutting-edge technology and an extensive database of primate genetic data, the company develops innovative tools that empower researchers to uncover new genetic targets and develop cures for rare and complex diseases.
For more information about CodeXome and Cornerstone Genomics, please visit http://www.cornerstonegenomics.com

About FITCI
About the Frederick Innovative Technology Center, Inc.: Nonprofit FITCI fosters entrepreneurial activity in Frederick, Maryland's science and technology industries. Its purpose is to enable the richly diverse field of emerging entrepreneurs; encourage innovation; and accelerate the development of commercially viable businesses that create the foundation of a healthy economy by providing equitable access to coaching, connections, and capital resources within a cooperative environment. http://www.fitci.org, 301-694-2999

Media Contact

Jill Pecon-Slattery, Cornerstone Genomics, 301-694-2999, [email protected], www.cornerstonegenomics.com

SOURCE Cornerstone Genomics

Modal title

Utilize 80 million years of evolutionary data to transform your understanding of genetic variations and improve human health.
Utilize 80 million years of evolutionary data to transform your understanding of genetic variations and improve human health.
Utilize 80 million years of evolutionary data to transform your understanding of genetic variations and improve human health.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.